Mirae Asset Global Investments Portfolio holdings
AUM
$28.7B
1-Year Return
20.96%
This Quarter Return
+7.12%
1 Year Return
+20.96%
3 Year Return
+114.88%
5 Year Return
+202.83%
10 Year Return
+496.23%
AUM
$20.1B
AUM Growth
-$26B
(-56%)
Cap. Flow
-$35.8B
Cap. Flow
% of AUM
-178.2%
Top 10 Holdings %
Top 10 Hldgs %
37.49%
Holding
2,693
New
259
Increased
178
Reduced
1,071
Closed
1,170
Top Buys
| 1 |
SPDR S&P 500 ETF Trust
SPY
|
+$78.3M |
| 2 |
Invesco QQQ Trust
QQQ
|
+$69.3M |
| 3 |
iShares Core MSCI Emerging Markets ETF
IEMG
|
+$67.8M |
| 4 |
SPDR Portfolio Long Term Treasury ETF
SPTL
|
+$51.6M |
| 5 |
Vanguard S&P 500 ETF
VOO
|
+$49.3M |
Top Sells
| 1 |
NVIDIA
NVDA
|
+$3.09B |
| 2 |
Microsoft
MSFT
|
+$2.03B |
| 3 |
Apple
AAPL
|
+$1.62B |
| 4 |
Amazon
AMZN
|
+$1.15B |
| 5 |
Meta Platforms (Facebook)
META
|
+$886M |
Sector Composition
| 1 | Technology | 34.49% |
| 2 | Consumer Discretionary | 8.59% |
| 3 | Communication Services | 8.54% |
| 4 | Healthcare | 6.84% |
| 5 | Financials | 4.59% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1401
Castle Biosciences
CSTL
$621M
| $17.4K | ﹤0.01% |
824
-10,908
| -93% | -$231K |
|
|
ITOS
1402
DELISTED
iTeos Therapeutics
ITOS
| $17.3K | ﹤0.01% |
1,113
-10,185
| -90% | -$158K |
|
1403
Regenxbio
RGNX
$465M
| $17.1K | ﹤0.01% |
1,471
-168,747
| -99% | -$1.96M |
|
1404
Phinia Inc
PHIN
$2.26B
| $17.1K | ﹤0.01% |
+440
| New | +$17.1K |
|
1405
Mineralys Therapeutics
MLYS
$2.88B
| $17K | ﹤0.01% |
+1,482
| New | +$17K |
|
|
WSR
1406
Whitestone REIT
WSR
$664M
| $16.8K | ﹤0.01% |
1,295
-19,064
| -94% | -$247K |
|
1407
Humacyte
HUMA
$233M
| $16.7K | ﹤0.01% |
+3,555
| New | +$16.7K |
|
|
GOOD
1408
Gladstone Commercial Corp
GOOD
$608M
| $16.3K | ﹤0.01% |
1,152
-16,939
| -94% | -$239K |
|
1409
Y-mAbs Therapeutics
YMAB
$390M
| $16.2K | ﹤0.01% |
+1,310
| New | +$16.2K |
|
1410
HUTCHMED
HCM
$3.08B
| $16.1K | ﹤0.01% |
+926
| New | +$16.1K |
|
|
GMRE
1411
Global Medical REIT
GMRE
$512M
| $16K | ﹤0.01% |
1,794
-28,626
| -94% | -$256K |
|
|
TIGR
1412
UP Fintech Holding
TIGR
$2B
| $15.9K | ﹤0.01% |
+3,686
| New | +$15.9K |
|
1413
Savara
SVRA
$615M
| $15.7K | ﹤0.01% |
+4,126
| New | +$15.7K |
|
|
THRD
1414
DELISTED
Third Harmonic Bio
THRD
| $15.7K | ﹤0.01% |
+1,223
| New | +$15.7K |
|
1415
Replimune Group
REPL
$447M
| $15.6K | ﹤0.01% |
1,834
-37,356
| -95% | -$318K |
|
1416
SIGA Technologies
SIGA
$639M
| $15.6K | ﹤0.01% |
2,123
-19,738
| -90% | -$145K |
|
|
CNTA
1417
Centessa Pharmaceuticals
CNTA
$2.92B
| $15.5K | ﹤0.01% |
+1,730
| New | +$15.5K |
|
|
HUYA
1418
Huya Inc
HUYA
$780M
| $15.5K | ﹤0.01% |
4,028
-180,602
| -98% | -$694K |
|
1419
Olaplex Holdings
OLPX
$947M
| $15.4K | ﹤0.01% |
+9,726
| New | +$15.4K |
|
1420
Marathon Digital Holdings
MARA
$6.04B
| $15.4K | ﹤0.01% |
774
-794,354
| -100% | -$15.8M |
|
1421
Galapagos
GLPG
$2.11B
| $15.3K | ﹤0.01% |
+607
| New | +$15.3K |
|
1422
Adaptive Biotechnologies
ADPT
$1.92B
| $15.2K | ﹤0.01% |
4,400
-46,079
| -91% | -$159K |
|
1423
Allogene Therapeutics
ALLO
$251M
| $15.2K | ﹤0.01% |
6,233
-355,680
| -98% | -$868K |
|
1424
KalVista Pharmaceuticals
KALV
$708M
| $15.2K | ﹤0.01% |
1,260
-9,375
| -88% | -$113K |
|
|
FPI
1425
Farmland Partners
FPI
$481M
| $15.1K | ﹤0.01% |
1,318
-23,221
| -95% | -$265K |
|